NL
Nikhil Lalwani
President & CEODirector

Nikhil Lalwani insider trades: Ani Pharmaceuticals (ANIP) stock buys and sales

President & CEO, Ani Pharmaceuticals Last trade Oct 15, 2026 32 Form 4 filings
$5.4M
Sold, last 12 months
4 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2022
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Nikhil reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 15, 2026ANIP↓ Sell$388K
Sep 15, 2026ANIP↓ Sell$383K
Aug 25, 2026ANIP↓ Sell$401K
May 11, 2026ANIP↓ Sell$4.3M
Aug 12, 2025ANIP↓ Sell$4.9M
Nov 26, 2024ANIP↓ Sell$1.9M
May 14, 2024ANIP↓ Sell$1.1M
Mar 8, 2024ANIP↓ Sell$3.0M
Aug 15, 2023ANIP↓ Sell$4.0M
Mar 21, 2022ANIP↑ Buy$200K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ANIP insiders

Open-market trades in the last 12 months

About Nikhil Lalwani's insider trades

Nikhil Lalwani is President & CEO at Ani Pharmaceuticals (ANIP). Since Mar 21, 2022, Nikhil has reported 1 open-market purchase worth $200K and 9 sales worth $20.4M on SEC Form 4. In the last 12 months: 4 sales ($5.4M).

Their filings also include shares withheld for taxes (17 filings), grants and awards (8 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANIP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.